CytoAgents Funding & Investors
CytoAgents is a clinical stage biotechnology company focused on the development of innovative pharmaceutical products for the treatment of life-threatening symptoms associated with Cytokine Release Syndrome (CRS), an overreaction of the immune system causing systemic inflammation also known as cytokine storm.
cytoagents.comTotal Amount Raised: $17,206,500
CytoAgents Funding Rounds
Series A
$7,000,000
Series A Investors
PCG CapitalBlueTree Allied AngelsSeed
$50,000
Seed Investors
Innovation WorksAlphaLab HealthSeries Unknown
$6,106,500
Seed
$100,000
Seed Investors
Innovation WorksGrant
$2,000,000
Grant Investors
National Institutes of Health (NIH)Grant
$250,000
Grant Investors
Richard King Mellon FoundationGrant
$1,600,000
Grant Investors
National Institutes of Health (NIH)Seed
$100,000
Seed Investors
Innovation Works
Funding info provided by Diffbot.